Skip to main content

Situational awareness: Cue Health, the VC-backed rapid diagnostics startup that went public at a $3 billion valuation in September, is laying off 170 people, while Egyptian health tech startup Vezeeta reportedly cut its workforce by 10%.

Artwork: Brendan Lynch/Axios

That of the Supreme Court the annulment of Roe v. Wade could lead to increased investment in women’s health and related technologies.

What they say : “It’s going to drive innovation out of necessity,” said Goodwin Procter attorney Delphine O’Rourke. Said Sarah.

  • O’Rourke adds that she has already received calls from people who are considering a dedicated fund for investment and innovation in women’s health.

Enlarge: VC-backed DTC startups like Tia, Choice, Hey Jane, AidAccess and Just the Pill, which already prescribe abortion pills, are already seeing a surge in demand, according to Fierce Healthcare.

  • Kelso and Juggernaut, the two physical education stores behind top-selling morning-after pills, Plan B, could see their profits surge as women stock up on emergency contraceptive pills. Especially given Judge Clarence Thomas’ suggestion to reevaluate decisions like Griswold (the right to contraception).
  • O’Rourke also expects more investment in safe-haven states like California. If you have a fertility clinic and “can absorb patients who will be traveling, that’s an opportunity,” she notes, adding that clinics are also navigating how to ship embryos across EU borders. State.

Other areas of investment O’Rourke cites virtual mental health, where there could be an increase in demand for services tailored to postpartum depression, startups that examine the quality of embryos, and training offers for healthcare companies. seeking to navigate the new legal landscape.

  • Plus, the technology around the security and privacy that surrounds the service you’ve already invested in.

Yes and: Don’t assume because it doesn’t directly affect women’s health that there won’t be an impact, O’Rourke says.

  • For example, if you’re providing primary care to women on Medicaid and they’re worried about state law, they won’t come to you. “It’s a chilling effect,” says O’Rourke.

The bottom line: “[Access to women’s health] is a hugely unmet need in a large market, and rational investors see it as an opportunity,” says Sasha Kelemen, banker at SVB Securities. “It’s a very personal mission. The best companies will still transcend.”